🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVcPqP #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
September 23, 2026 at 3:00 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVcPqP #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
#ProQR impressive preclinical AX-0810 cholestatic disease #ASGCT25 abstract. Clinical candidate shows >50% #RNAediting.
Robust changes in biomarkers (serum bile acids; conjugated/unconjugated ratio) already at less editing.
Robust changes in biomarkers (serum bile acids; conjugated/unconjugated ratio) already at less editing.
May 13, 2025 at 9:49 AM
#ProQR impressive preclinical AX-0810 cholestatic disease #ASGCT25 abstract. Clinical candidate shows >50% #RNAediting.
Robust changes in biomarkers (serum bile acids; conjugated/unconjugated ratio) already at less editing.
Robust changes in biomarkers (serum bile acids; conjugated/unconjugated ratio) already at less editing.
The @ucl.ac.uk IoN GTAC AAV team had a wonderful time at #ASGCT25! Thank you everyone for the inspiring work and enlightening discussions! @profjng.bsky.social Rebeca Gil Hester Chu Camila Vallve Kristina Zhelcheska 🧬
@asgct.bsky.social New Orleans, LA
@asgct.bsky.social New Orleans, LA
May 20, 2025 at 4:36 PM
The @ucl.ac.uk IoN GTAC AAV team had a wonderful time at #ASGCT25! Thank you everyone for the inspiring work and enlightening discussions! @profjng.bsky.social Rebeca Gil Hester Chu Camila Vallve Kristina Zhelcheska 🧬
@asgct.bsky.social New Orleans, LA
@asgct.bsky.social New Orleans, LA
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TPnWL3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
December 12, 2025 at 7:06 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TPnWL3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLmD5k #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
July 6, 2025 at 2:59 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLmD5k #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
The 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗚𝗲𝗻𝗲 & 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 #𝗔𝗦𝗚𝗖𝗧 annual meeting will soon be here, and more precisely in New Orleans May 13-17, 2025.
The abstract deadline is February 4th and registration is live!
#ASGCT25 #ASGCT2025 is #CRISPR #AAV #LNP #GeneEditing #CellTherapy and much more
The abstract deadline is February 4th and registration is live!
#ASGCT25 #ASGCT2025 is #CRISPR #AAV #LNP #GeneEditing #CellTherapy and much more
February 4, 2025 at 1:35 AM
The 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗚𝗲𝗻𝗲 & 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 #𝗔𝗦𝗚𝗖𝗧 annual meeting will soon be here, and more precisely in New Orleans May 13-17, 2025.
The abstract deadline is February 4th and registration is live!
#ASGCT25 #ASGCT2025 is #CRISPR #AAV #LNP #GeneEditing #CellTherapy and much more
The abstract deadline is February 4th and registration is live!
#ASGCT25 #ASGCT2025 is #CRISPR #AAV #LNP #GeneEditing #CellTherapy and much more
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TS6NpG #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
April 19, 2026 at 9:23 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TS6NpG #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TQxgFL #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
February 13, 2026 at 7:09 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TQxgFL #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TP6707 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
November 6, 2025 at 10:19 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TP6707 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
#ProQR said yesterday they are still in late stages of experiments ahead of CTA filing and data still on track for 2025.
So I expect CTA to slip into Q3. Today important presentation on what hope is the clinical candidate at #asgct25. #RNAediting
www.biotechtv.com/post/proqr-a...
So I expect CTA to slip into Q3. Today important presentation on what hope is the clinical candidate at #asgct25. #RNAediting
www.biotechtv.com/post/proqr-a...
ASGCT 2025: The Co-Founder of ProQR discusses the company's Axiomer RNA base editing technology - which will see a CTA filed this quarter and data by the end of the year
ProQR Co-Founder & CSO Gerard Platenburg describes the company's RNA editing platform and the journey he has seen this field go through over time. Plus, updates on programs for cholestatic diseases, R...
www.biotechtv.com
May 16, 2025 at 10:04 AM
#ProQR said yesterday they are still in late stages of experiments ahead of CTA filing and data still on track for 2025.
So I expect CTA to slip into Q3. Today important presentation on what hope is the clinical candidate at #asgct25. #RNAediting
www.biotechtv.com/post/proqr-a...
So I expect CTA to slip into Q3. Today important presentation on what hope is the clinical candidate at #asgct25. #RNAediting
www.biotechtv.com/post/proqr-a...
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TV3FBy #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
August 17, 2026 at 3:00 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TV3FBy #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVL5wC #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
September 5, 2026 at 8:00 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVL5wC #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TNr4Z0 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
October 23, 2025 at 9:22 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TNr4Z0 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TNjFpJ #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
October 16, 2025 at 7:59 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TNjFpJ #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLv6z5 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
July 13, 2025 at 6:07 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLv6z5 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 26% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLDQD3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
ASGCT_2025_Social_Media_Report_by_LucidQuest.pdf
This preview is powered by Bitly
Bitly is dedicated to making the internet a safer place for everyone.
Use the site preview above to make sure the link takes you where you expect.
dlvr.it
June 7, 2025 at 6:05 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 26% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TLDQD3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVSzLc #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
September 14, 2026 at 9:21 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVSzLc #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVBMt4 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
August 26, 2026 at 6:07 PM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVBMt4 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TTwFw3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
August 8, 2026 at 9:21 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TTwFw3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TTmgm3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
July 30, 2026 at 8:01 AM
🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TTmgm3 #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@ASGCTherapy @ESGCT
Feed: "Endpoints News"
By: Lei Lei Wu on Friday, May 16, 2025
By: Lei Lei Wu on Friday, May 16, 2025
#ASGCT25: In three patients, Rocket’s second heart gene therapy shows promise
Rocket Pharmaceuticals reports early success in gene therapy trial for heart condition PKP2-ACM, with 3 patients showing improved heart function. One had severe side effects.
endpts.com
May 17, 2025 at 3:33 PM
Feed: "Endpoints News"
By: Lei Lei Wu on Friday, May 16, 2025
By: Lei Lei Wu on Friday, May 16, 2025
Feed: "Endpoints News"
By: Ryan Cross on Friday, May 16, 2025
By: Ryan Cross on Friday, May 16, 2025
#ASGCT25: Lower conference attendance mirrors challenged cell and gene field
American Society of Gene & Cell Therapy meeting sees 10% drop in attendance. Notable absences include FDA officials, David Liu, Patrick Hsu & CRISPR Therapeutics amid funding concerns.
endpts.com
May 17, 2025 at 3:33 PM
Feed: "Endpoints News"
By: Ryan Cross on Friday, May 16, 2025
By: Ryan Cross on Friday, May 16, 2025